K
eloids are benign fibroproliferative cutaneous tumors that occur as an extreme of abnormal wound healing. 1 There is no universally accepted therapy for keloids, which often recur. [2] [3] [4] This is in part because the molecular mechanisms driving keloid recurrence are unknown. Developing a better understanding of this disease and a treatment protocol that can prevent their recurrence would significantly impact the lives of patients. 3 Studying keloids is complicated by the lack of in vitro and animal models. 5 Microarrays of keloidderived fibroblasts [6] [7] [8] [9] and keratinocytes 10, 11 have been used to characterize the cellular response to therapy. These data have produced valuable insights into inflammatory drivers of this disease.
However, these analyses have yet to identify definitive disease progression markers. We may improve our understanding of keloids by studying them in their native three-dimensional context. 12 Acquiring enough clinical biopsy specimens of keloids to permit global gene expression with sufficient statistical power is challenging. Machine learning algorithms, such as random forest analysis, can overcome this difficulty by performing thousands of rounds of analysis on global gene expression arrays to create a predictive gene expression profile with a low percentage of false-positive results. 13 In this study, we use a treatment method of keloid excision and postoperative injection with 5-fluorouracil with a 100 percent response rate and no recurrences after 2 years. We also describe two methods of studying keloid response Disclosure: None of the authors has any financial arrangements or potential conflicts of interest related to this article. Summary: Keloids are benign fibroproliferative skin tumors that can cause disfigurement and disability. Although they frequently recur after excision or medical management and can affect 6 to 16 percent of African Americans, there is no gold standard therapy. Keloids are challenging to study because there are no animal or in vitro models of this disorder. This makes it very difficult to validate data from treated tissue samples or cells and develop targeted therapies for this disease. In this study, the authors demonstrate that intralesional 5-fluorouracil injection after keloid excision prevents recurrence for 2 years, with no reported adverse events. The authors analyze the expression of treated and untreated biopsy specimens of the same keloids in their native context to capture insights that may be missed by in vitro cell culture models and correct for intrakeloid variability. Random forest analysis of the microarray data dramatically increased the statistical power of the authors' results, permitting hypothesis-free creation of a gene expression profile of 5-fluorouracil-treated keloids. Through this analysis, the authors found a set of genes, including YAP1 and CCL-2, whose expression changes predict 5-fluorouracil therapy status and include genes that have not previously been associated with keloid biology and are of unknown function. The authors further describe keloid heterogeneity for the first time using multidimensional analysis of their microarray results. The methods and tools the authors developed in this research may overcome some of the challenges in studying keloids and developing effective treatments for this disease. to therapeutics: biopsy of treated and untreated regions for genetic analysis, and random forests to generate a gene-expression profile for treated keloids.
PATIENTS AND METHODS

5-Fluorouracil Keloid Treatment and Excision
All patients received a test injection in the keloid in the clinic. The keloids were then excised to grossly normal tissue and closed with Monocryl (Ethicon, Inc., Somerville, N.J.) sutures in the operating room. Specimens were taken from the area of injection and a remote area and placed in RNAlater (Sigma-Aldrich, St. Louis, Mo.). RNA was extracted from tissue samples with Trizol and the Qiagen RNeasy kit (Qiagen, Venlo, The Netherlands). The RNA was run on an Illumina Human HT-12v4 BeadChip (Illumina, Inc., San Diego, Calif.).
Postoperatively, patients were followed weekly and received their first injection into the incision at 2 weeks. 5-Fluorouracil was injected intradermally at a concentration of 50 mg/ml. Patients returned for subsequent injections at 1-to 2-week intervals 14 for four rounds of injection. After completion of the 5-fluorouracil treatment, patients were scheduled for follow-up at 3, 6, and 12 months and then annually for assessment of their scars.
Statistical Analysis
The microarray data of treated and untreated keloid biopsy specimens from four patients were annotated, and 26,682 coding regions were selected for further analysis based on their statistical significance (p < 0.05). This data set was then analyzed with the random forest analysis algorithm to test separation among the treated and untreated samples and identify top contributors to that separation. Random forest analysis was performed on the genes by generating 50,000 trees. 15 The results of the random forest were then visualized using multidimensional scaling. The paired t test and the fold change were calculated for the top 100 genes from the random forest analysis. Hochberg multiple test correction was performed on p values. 16 
RESULTS
In this study, the keloids of four patients were excised and then the wound bed was treated with 5-fluorouracil. These patients did not develop adverse events and showed no recurrence over 2 years of follow-up (Fig. 1) .
For genetic analysis of the keloid response to 5-fluorouracil treatment, we compared microarray results from treated and untreated regions of the same keloid to reduce statistical noise and investigate intrakeloid heterogeneity. Evaluation of the similarity in expression profiles by hierarchical clustering revealed that treated and untreated samples of the same keloid clustered by treatment status. Neither publically available keloid-derived fibroblast or keratinocyte microarray data 11 clustered with keloids, highlighting the difference 
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between two-dimensional culture and the keloid microenvironment (Fig. 2) . These results suggest that we can detect distinct expression profiles for treated and untreated portions of keloids.
We used random forest analysis to determine the 100 genes that were most predictive of keloid treatment. We then calculated the Pearson correlation coefficient (a measure of similarity in the expression network) between each keloid sample relative to every other sample. Multidimensional analysis of this data set 17 showed separation of keloids into clusters separated by treatment status (Fig. 3) , visualizing the transcriptional difference between treated and untreated keloids.
To produce a list of genes that are most likely to influence keloid response to treatment, we selected genes that most influenced the accuracy of the random forest model. We also calculated the Q scores (the chance of a result being a false-positive) for these genes before and after random forest analysis (Fig. 4) . Repression of YAP1, a profibrotic gene associated with skin fibrosis, [18] [19] [20] [21] and up-regulation of CCL2, a regulator of T-cell activity downstream of transforming growth factor-β, 22 was seen in treated keloids. Furthermore, there was no change in the expression of several genes previously linked to keloids: transforming growth factor-β; platelet-derived growth factor; matrix metalloproteinases; and interleukins (IL) 1, 6, and 10. We used ingenuity pathway analysis to detect gene networks impacted by 5-fluorouracil treatment of whole keloids. Glycosaminoglycan protein linkage region biosynthesis and IL-17A pathways were altered, agreeing with research showing the importance of glycosaminoglycans 23 and IL-17A signaling in keloid biology. 24 These results show that machine learning can be used to create a genetic profile of keloids successfully treated with 5-fluorouracil. 
DISCUSSION
In this study, we evaluated a keloid treatment protocol and two new methods for facilitating the mechanistic study of keloids: taking treated and untreated biopsy specimens from the same tumor and using random forest analysis to find significant genes. These methods may help us overcome the lack of in vitro or animal models for keloids by increasing the statistical power we can generate from small numbers of biopsy specimens. 25 Our initial results implicate some drivers of keloid responsiveness to 5-fluorouracil treatment. Further study of these and the uncharacterized genes resulting from this study may help us design more targeted strategies for treating and ultimately curing this disfiguring disease.
